Discovery launches integrated flow cytometry clinical trial services

(Discovery Life Sciences/LinkedIn contributed)

HUNTSVILLE — Discovery Life Sciences has launched a state-of-the-art flow cytometry clinical trial services.

Discovery has integrated Cytek Aurora instruments, which engage full-spectrum technology to deliver unprecedented flexibility to researchers, into one facility alongside its genomics, molecular pathology, and proteomics services. The process saves valuable time and further assuring high quality for drug and diagnostic development, Discovery said.

The addition of clinical flow cytometry strengthens the biospecimen and biomarker specialists’ position as a leading specialty contract laboratory.

Researchers will now benefit from advanced instrumentation that enables the simultaneous analysis of up to 40 color combinations, significantly enhancing efficiency and accuracy in their clinical trial data collection and analysis.

Discovery’s clients can select specific parameters that align with their research objectives, enabling rapid immuno-monitoring and a deeper understanding of complex biological systems.

They also can access a market-leading combination of technologies and expertise across a comprehensive suite of services, including multi-parameter flow cytometry, blood and tissue biospecimens, genomics profiling, proteomics analysis, and molecular pathology.

“We are excited to add the power of the newest Cytek Aurora instruments along with the scientific expertise in clinical flow cytometry services to our company,” said Glenn Bilawsky, CEO of Discovery. “This investment furthers our commitment to providing researchers with the most advanced technology and scientific consultation to support their clinical trial needs.

“By combining clinical flow cytometry services into the same facility and supporting data system as genomics, proteomics, and molecular pathology services, we will accelerate our clients’ development of life-changing therapies even further.”

Discovery’s clinical flow cytometry services are backed by a team of highly skilled scientists and researchers with extensive experience in clinical trial regulations, compliance, and support.

The company’s dedication to quality assurance, data security, and compliance provides clients with accurate, reliable, and submissible results rapidly and at any scale, the company said.

Recent in Biotechnology

HUNTSVILLE — “Fueling an ecosystem to ignite biopharma innovation in Rocket City.” That was the title of the panel discussion Tuesday where Eli Lilly CEO David Ricks announced his company […]

HUNTSVILLE – HudsonAlpha Institute for Biotechnology, in partnership with venture firm and startup accelerator gener8tor, has launched its Fall 2025 AgTech Accelerator featuring 10 startup companies selected for the cohort. […]

Next Post

Strong: Defense bill boosts pay, targets adversaries

Grayson Everett July 14, 2023